Work

Investigation of the Mechanism of Action and IOP Lowering Ability of CB1 Agonists using Glauconix Biosciences’ 3D-HTMTM Tissue Model

Year: 2019

Type: article

Source: Investigative Ophthalmology & Visual Science

Authors: Andrea Unser, Aishwarya Panneerselvam, Feryan Ahmed, George Torrejon, Karen Y. Torrejon

Institution: Glauconix (United States)

Language: English

Topic: Glaucoma and retinal disorders

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,850

OpenAlex ID: W3137258443

FWCI:

Cites:

Cited by:

Related to: 10